The Cannabis ETF (THCX)
ARCA ARCA Primary 
Top Ancillary Cannabis Stocks to Watch Before 2025
The US cannabis industry continues to expand, with sales projected to reach $41 billion by 2025, according to recent data. Ancillary cannabis companies, which provide essential products and services to growers and retailers, remain key players in this growth. These businesses benefit from industry expansion without directly handling the plant, reducing regulatory risks. Recent headlines highlight ongoing federal legalization discussions, signaling potential reforms to drive future demand. This week offers investors a prime opportunity to monitor top ancillary cannabis stocks as the market evolves.
Village Farms Set To Grow In 2025 With Dutch Cannabis Revenues
Village Farms reported Q3 financial results last month which show improvements and free cash flow. VFF has completed its growth facility in the Netherlands and has increased its international sales. Village Farms will testify in the coming months at the DEA's hearings to reschedule cannabis.
Top Ancillary Cannabis Stocks Showing Momentum This Week
The cannabis sector has experienced a significant pullback recently, largely influenced by ongoing regulatory challenges and market conditions. Despite these setbacks, the ancillary cannabis market continues to show resilience and potential for growth. Ancillary companies, which provide critical services and products to the cannabis industry without directly touching the plant, play an essential role in the supply chain. These companies are often more insulated from regulatory uncertainties, making them attractive to investors seeking exposure to cannabis without direct risks.
3 Cannabis Stocks In The Public Sector You Should Know About
Cannabis stock investors face another complex year ahead. The reason for this is the politics surrounding cannabis reform. For as long as pot stocks have been publicly traded, the pros and cons of reform have always impacted trading. With how far the industry has come, speculation on what will take place in 2025 has amped up. The global cannabis market has consistently generated billions of dollars.
Boston Beer Introduces a Line of Alcohol-Free Cannabis Cocktails
SAM launches Emerald Hour, a new lineup of non-alcoholic Cali Sober cannabis cocktails.
85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading
The cannabis sector's Q3 performance has been a mixed bag, but two companies stood out for their exceptional financial performance: Green Thumb Industries GTBIF and Glass House Brands GLASF.
Investing in Cannabis: Best Marijuana Stocks for December 2024
The cannabis industry has experienced significant turbulence in recent months. Following years of exponential growth, driven by increasing legalization and expanding consumer acceptance, the sector is now grappling with a substantial pullback. This downturn stems from regulatory challenges, market saturation in key regions, and shifting investor sentiment. However, despite recent setbacks, the long-term growth potential remains promising.
Top Picks: Ancillary Cannabis Stocks Gaining Momentum in the Past Month
The US cannabis industry continues to expand rapidly, presenting unique opportunities for investors in ancillary cannabis stocks. Analysts project the market could reach $100 billion in value by 2030 as legalization spreads across states. Ancillary companies like WM Technology, Hydrofarm, and NewLake Capital Partners provide essential services that support this growth. These businesses benefit from the demand for advertising platforms, cultivation equipment, and real estate solutions. Moreover, they offer an indirect way to invest in cannabis while avoiding risks tied to plant-touching operations. As the industry matures, ancillary stocks remain critical for long-term success.
Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania
VANCOUVER, BC / ACCESSWIRE / December 4, 2024 / (CSE:OVAT)(OTC PINK:OVATF) - Ovation Science Inc. ("Ovation" or the "Company"), with its patented topical and transdermal cannabis products powered by its proprietary skin delivery technology Invisicare®, announces the official launch of its products in Pennsylvania through its licensee: PA Options for Wellness Inc. ("PA Options"). The launch marks Ovation's second licensee in the USA and is part of the Company's on-going strategy to seek leading cannabis companies as licensees, state-by-state across the US.
NASDAQ-Listed High Tide Under The Magnifying Glass: Key Insights For Cannabis Investors
We've been offering some mid-term analysis for main cannabis stocks and now it's High Tide's HITI turn. The occasion couldn't be better, since the stock recently surged 21% in the previous rounds.
Best Canadian Cannabis Stocks for Your December 2024 Watchlist
The cannabis sector recently experienced a pullback after Florida voters did not pass recreational cannabis legalization. This has caused a temporary market dip, creating potential entry points for well-researched investors. Despite setbacks, the U.S. cannabis industry continues to expand. It generated $32 billion in sales in 2023 and is expected to surpass $50 billion by 2030. Federal legalization remains a critical catalyst, with Congress debating key reform bills. The SAFE Banking Act and the potential rescheduling of cannabis under the Controlled Substances Act have dominated recent headlines. Investors should stay informed about these developments to understand their market impact.
Top Cannabis Stocks For Investors To Know About It
Over the last several years, the cannabis industry has experienced a significant change. The industry has ripened from a stigmatized market to one of the fastest-growing sectors in the economy. As legalization efforts continue and societal perspectives shift, investing in cannabis stocks is an enticing opportunity for forward-thinking investors. Here's a glimpse at why marijuana stocks illustrate the tomorrow of investing and how the legal market continues to develop.
